Share

Pharmaceutical companies under fire for high price of cancer drugs

To sign the petition, click Protest High Cancer Drug Prices.

Advertisement

The average cost of cancer drugs per month is now situated at about $10,000, about one fifth of the U.S. average household income.

Also, in the article the doctors pointed out how the prices of cancer treatments increase every year. In america, all most cancers patients should have immediate entry to affordable prescription medications to conserve their life.

According to a NOLA.com report, there has been a steep rise in the price of cancer drugs with cancer drugs rising by an average of a whopping $8,500 per year in the last 15 years. It alleged that dropping the cost of medicines would slow down the development of breakthrough cancer research. A treatment with a $120,000-per-year bill typically results in out-of-pocket expenses up to $25,000 or $30,000, even after an insurance company pays its share, as stated by Immortal.org.

Dr. Ayalew Tefferi, a hematologist at the Mayo Clinic in Rochester, Minnesota, said in a news release that the high cost of cancer drugs is “affecting the care of patients with cancer and our health care system”, HealthDay News reported. This can be an injustice of which creates differential remedy conditioned by simply financial position.

The federal government should allow for the importation of cancer drugs from countries like Canada where they are much cheaper.

The doctors proposed legislation that would allow Medicare to negotiate prices directly with pharmaceutical companies, driving down prices for patients.

With families giving up half their income for certain cancer drugs, it’s no wonder why a few doctors would speak out against the outrageous pricing. “It’s time for patients and their physicians to call for change”.

We believe the measures as outlined above, will allow market forces to work in favor of lower cancer drug prices.

Advertisement

Encourage organizations that represent cancer specialists and patients to consider the overall value of drugs and treatments in formulating treatment guidelines. “Pharmaceutical companies are usually in greed function, and it’s sad”.

118 Cancer Specialists Decry Rising Cancer Drug Prices